Opportunity ID: 322862

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DK-19-036
Funding Opportunity Title: Clinical Trials to Test Artificial Pancreas Device Systems in Populations Challenging to Manage Type 1 Diabetes (T1D) (U01 Clinical Trial Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Dec 04, 2019
Last Updated Date: Apr 14, 2020
Original Closing Date for Applications: Apr 09, 2020
Current Closing Date for Applications: Jul 09, 2020
Archive Date: Aug 08, 2020
Estimated Total Program Funding: $3,000,000
Award Ceiling: $1,000,000
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
City or township governments
Public and State controlled institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
Special district governments
Public housing authorities/Indian housing authorities
For profit organizations other than small businesses
County governments
Private institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description:

This FOA will support the conduct of clinical trials designed to test the clinical safety and efficacy of artificial pancreas (AP) device systems with the objective of improving glycemic control, reducing acute complications and improving quality of life in people with difficult to control T1D when using standard of care therapies.

Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-036.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date
Updated expiration date in accordance with NOT-OD-20-091 Apr 14, 2020
Dec 04, 2019

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DK-19-036
Funding Opportunity Title: Clinical Trials to Test Artificial Pancreas Device Systems in Populations Challenging to Manage Type 1 Diabetes (T1D) (U01 Clinical Trial Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Dec 04, 2019
Last Updated Date: Apr 14, 2020
Original Closing Date for Applications: Apr 09, 2020
Current Closing Date for Applications: Jul 09, 2020
Archive Date: Aug 08, 2020
Estimated Total Program Funding: $3,000,000
Award Ceiling: $1,000,000
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
City or township governments
Public and State controlled institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
Special district governments
Public housing authorities/Indian housing authorities
For profit organizations other than small businesses
County governments
Private institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description:

This FOA will support the conduct of clinical trials designed to test the clinical safety and efficacy of artificial pancreas (AP) device systems with the objective of improving glycemic control, reducing acute complications and improving quality of life in people with difficult to control T1D when using standard of care therapies.

Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-036.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DK-19-036
Funding Opportunity Title: Clinical Trials to Test Artificial Pancreas Device Systems in Populations Challenging to Manage Type 1 Diabetes (T1D) (U01 Clinical Trial Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Dec 04, 2019
Last Updated Date: Dec 04, 2019
Original Closing Date for Applications:
Current Closing Date for Applications: Apr 09, 2020
Archive Date: May 15, 2020
Estimated Total Program Funding: $3,000,000
Award Ceiling: $1,000,000
Award Floor:

Eligibility

Eligible Applicants: Public housing authorities/Indian housing authorities
For profit organizations other than small businesses
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Independent school districts
Special district governments
Public and State controlled institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
Small businesses
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This FOA will support the conduct of clinical trials designed to test the clinical safety and efficacy of artificial pancreas (AP) device systems with the objective of improving glycemic control, reducing acute complications and improving quality of life in people with difficult to control T1D when using standard of care therapies.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-036.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or after May 25, 2020 PKG00259549 Mar 09, 2020 Apr 09, 2020 View
FORMS-E Use for due dates on or before May 24, 2020 PKG00257000 Mar 09, 2020 Jul 09, 2020 View

Package 1

Mandatory forms

322862 RR_SF424_2_0-2.0.pdf

322862 PHS398_CoverPageSupplement_5_0-5.0.pdf

322862 RR_OtherProjectInfo_1_4-1.4.pdf

322862 PerformanceSite_2_0-2.0.pdf

322862 RR_KeyPersonExpanded_2_0-2.0.pdf

322862 PHS398_ResearchPlan_4_0-4.0.pdf

322862 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

322862 RR_Budget_1_4-1.4.pdf

322862 RR_SubawardBudget30_1_4-1.4.pdf

322862 PHS398_ModularBudget_1_2-1.2.pdf

322862 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

322862 RR_SF424_2_0-2.0.pdf

322862 PHS398_CoverPageSupplement_4_0-4.0.pdf

322862 RR_OtherProjectInfo_1_4-1.4.pdf

322862 PerformanceSite_2_0-2.0.pdf

322862 RR_KeyPersonExpanded_2_0-2.0.pdf

322862 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

322862 RR_Budget_1_4-1.4.pdf

322862 RR_SubawardBudget30_1_4-1.4.pdf

322862 PHS398_ModularBudget_1_2-1.2.pdf

322862 PHS_AssignmentRequestForm_2_0-2.0.pdf

2025-07-09T11:20:49-05:00

Share This Post, Choose Your Platform!

About the Author: